ALVO – alvotech (US:NASDAQ)
Stock Stats
News
Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio® [Yahoo! Finance]
Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio®
Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Alvotech Second Quarter 2024 Earnings: EPS: US$0.25 (vs US$0.83 in 2Q 2023) [Yahoo! Finance]
Alvotech's (NASDAQ:ALVO) biggest owners are private equity firms who got richer after stock soared 19% last week [Yahoo! Finance]
Form EFFECT Alvotech
Form 424B3 Alvotech
Form F-3 Alvotech
Form 6-K Alvotech For: Jun 30
Form 6-K Alvotech For: Aug 15
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.